Management of Patients with Urological Cancers in Turkey during the COVID-19 Pandemic: Recommendations of Uro-oncology Association

被引：3

作者：

Celik, Serdar ^{[1
,2
]}

Tinay, Ilker ^{[3
]}

Narter, Fehmi ^{[4
]}

Eskicorapci, Saadettin ^{[5
]}

Ataus, Suleyman ^{[6
]}

Turkeri, Levent ^{[7
]}

Baltaci, Sumer ^{[8
]}

机构：

[1] Univ Hlth Sci Turkey, Izmir Bozyaka Training & Res Hosp, Clin Urol, Izmir, Turkey

[2] Dokuz Eylul Univ, Dept Basic Oncol, Inst Oncol, Izmir, Turkey

[3] Marmara Univ, Dept Urol, Fac Med, Istanbul, Turkey

[4] Mehmet Ali Aydinlar Univ, Kadikoy Hosp, Clin Urol, Istanbul, Turkey

[5] Mehmet Ali Aydinlar Univ, Atakent Hosp, Clin Urol, Istanbul, Turkey

[6] Forte Urol Ctr, Istanbul, Turkey

[7] Mehmet Ali Aydinlar Univ, Clin Urol, Altunizade Hosp, Istanbul, Turkey

[8] Ankara Univ, Dept Urol, Fac Med, Ankara, Turkey

来源：

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2020年 / 19卷 / 03期

关键词：

COVID-19; pandemic; recommendations; urologic cancers; urologic oncology; RADICAL CYSTECTOMY; BLADDER; DELAY; SURVEILLANCE; SEMINOMA;

D O I：

10.4274/uob.galenos.2020.1810

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Coronavirus disease-19 (COVID-19) has been declared as a pandemic by the World Health Organization. The number of cases has increased over time in correlation with the increasing number of testing worldwide. In order to use the available resources for COVID-19 treatment, urological practice has been limited only to emergency procedures and certain uro-oncological surgeries. In this report, we aim to share our recommendations for the daily uro-oncology practice in light of local circumstances in Turkey.

引用

页码：100 / 103

页数：4

共 23 条

[1]

[Anonymous], 2016, UROL ONCOL

[2]

Ayres BE, 2008, BJU INT, V102, P1045, DOI [10.1111/j.1464-410X.2008.08084.x, 10.1111/j.1464-410X.2008.08084_1.x]

[3] Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guerin [J].

Baltaci, Sumer ;

Bozlu, Murat ;

Yildirim, Asif ;

Gokce, Mehmet Ilker ;

Tinay, Ilker ;

Aslan, Guven ;

Can, Cavit ;

Turkeri, Levent ;

Kuyumcuoglu, Ugur ;

Mungan, Aydin .

BJU INTERNATIONAL, 2015, 116 (05) :721-726

[4] Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes [J].

Boeri, Luca ;

Soligo, Matteo ;

Frank, Igor ;

Boorjian, Stephen A. ;

Thompson, R. Houston ;

Tollefson, Matthew ;

Quevedo, Fernando J. ;

Cheville, John C. ;

Karnes, R. Jeffrey .

EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (04) :390-396

[5] Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival [J].

Bourgade, Vincent ;

Drouin, Sarah J. ;

Yates, David R. ;

Parra, Jerome ;

Bitker, Marc-Olivier ;

Cussenot, Olivier ;

Roupret, Morgan .

WORLD JOURNAL OF UROLOGY, 2014, 32 (02) :475-479

[6] Cancer guidelines during the COVID-19 pandemic [J].

Burki, Talha Khan .

LANCET ONCOLOGY, 2020, 21 (05) :629-630

[7] Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review [J].

Cumberbatch, Marcus G. K. ;

Foerster, Beat ;

Catto, James W. F. ;

Kamat, Ashish M. ;

Kassouf, Wassim ;

Jubber, Ibrahim ;

Shariat, Shahrokh F. ;

Sylvester, Richard J. ;

Gontero, Paolo .

EUROPEAN UROLOGY, 2018, 73 (06) :925-933

[8] Destruction of the bladder by single dose Mitomycin C for low-stage transitional cell carcinoma (TCC) - avoidance, recognition, management and consent [J].

Elmamoun, Mamoun H. ;

Christmas, Tim J. ;

Woodhouse, Christopher R. J. .

BJU INTERNATIONAL, 2014, 113 (5B) :E34-E38

[9]

Ficarra V, 2020, MINERVA UROL NEFROL

[10] Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic [J].

Gillessen, Silke ;

Powles, Thomas .

EUROPEAN UROLOGY, 2020, 77 (06) :667-668

← 1 2 3 →